Annuncio pubblicitario
Italia markets close in 5 hours 12 minutes

  • FTSE MIB

    33.377,37
    -576,91 (-1,70%)
     

  • Dow Jones

    37.735,11
    -248,13 (-0,65%)
     

  • Nasdaq

    15.885,02
    -290,08 (-1,79%)
     

  • Nikkei 225

    38.471,20
    -761,60 (-1,94%)
     

  • Petrolio

    85,02
    -0,39 (-0,46%)
     

  • Bitcoin EUR

    59.411,25
    -3.267,22 (-5,21%)
     

  • CMC Crypto 200

    885,54
    0,00 (0,00%)
     

  • Oro

    2.390,40
    +7,40 (+0,31%)
     

  • EUR/USD

    1,0632
    +0,0006 (+0,05%)
     

  • S&P 500

    5.061,82
    -61,59 (-1,20%)
     

  • HANG SENG

    16.248,97
    -351,49 (-2,12%)
     

  • Euro Stoxx 50

    4.914,49
    -69,99 (-1,40%)
     

  • EUR/GBP

    0,8537
    +0,0002 (+0,02%)
     

  • EUR/CHF

    0,9702
    +0,0017 (+0,17%)
     

  • EUR/CAD

    1,4661
    +0,0018 (+0,12%)
     

Orion publishes Financial Statement Release for 2022 on Thursday 9 February 2023

Orion Oyj
·2 minuto per la lettura
Orion Oyj
Orion Oyj

ORION CORPORATION
PRESS RELEASE
26 January 2023 at 12.00 EET

Orion publishes Financial Statement Release for 2022 on Thursday 9 February 2023

Orion will publish Financial Statement Release for 2022 on Thursday, 9 February 2023 at approximately 12.00 noon EET. The report and related presentation material will be available on the company’s website at www.orion.fi/en/investors after publishing.

Webcast and conference call

A webcast and a conference call for analysts, investors and media representatives will be held on Thursday, 9 February 2023 at 13.30 EET.

A link to the live webcast is available on Orion's website at www.orion.fi/en/investors. A recording of the event will be available on the website later the same day.

ANNUNCIO PUBBLICITARIO

Confenrence call can be joined by registering through the following link:
http://palvelu.flik.fi/teleconference/?id=1009425

Phone numbers and the conference ID to access the conference will be provided after the registration. In case you would like to ask a question during the conference, please dial *5 on your telephone keypad to enter the question queue.

Questions can also be presented in writing through the question form of the webcast.

Silent period

The silent period preceding the publication is ongoing and continues until the disclosure.


Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.